Lisa Påhlman
1 – 10 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Treatment outcome with pencillin G or cloxacillin in penicillin susceptible Staphylococcus aureus bactearemi
(
- Contribution to journal › Article
- 2021
-
Mark
Genomic and phenotypic evolution of achromobacter xylosoxidans during chronic airway infections of patients with cystic fibrosis
(
- Contribution to journal › Article
-
Mark
Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection
(
- Contribution to journal › Article
-
Mark
Endocarditis due to Staphylococcus lugdunensis—a retrospective national registry–based study
(
- Contribution to journal › Article
-
Mark
Efficacy of Lactiplantibacillus plantarum 299 and 299v against nosocomial oropharyngeal pathogens in vitro and as an oral prophylactic treatment in a randomized, controlled clinical trial
(
- Contribution to journal › Article
- 2020
-
Mark
Commercial albumin solution enhances endotoxin-induced vasoplegia and inflammation
(
- Contribution to journal › Article
-
Mark
Evaluation of penicillin G susceptibility testing methods for Staphylococcus lugdunensis
(
- Contribution to journal › Article
-
Mark
Activity of airway antimicrobial peptides against cystic fibrosis pathogens
(
- Contribution to journal › Article
-
Mark
Risk of bacteremia in patients presenting with shaking chills and vomiting - A prospective cohort study
(
- Contribution to journal › Article
-
Mark
Respiratory adenovirus infections in immunocompetent and immunocompromised adult patients
(
- Contribution to journal › Article